Absci anticipates interim 13-week ABS-201 pattern hair loss data next month as it plans mid-2027 endometriosis Phase 2 start
Tickers: $ABSI
Topics: biotechnology clinical_trial_results drug_development
Read the full article at Seeking Alpha
Part of the story Absci Reports Q3 2026 Financial Results and Clinical Updates for ABS-201 (5 articles)